Global Influenza Diagnostics Market to reach USD 1092.9 million by 2026

Global Influenza Diagnostics Market Size study, by Test type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), by End user (Hospitals, Clinical Laboratories, Other End-User) and Regional Forecasts 2020-2026
Product Code:  HALMD_69016517
Chapter 1.	Executive Summary   
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)       
1.2.1.	Influenza Diagnostics Market, by Region, 2018-2026 (USD Million)
1.2.2.	Influenza Diagnostics Market, by Test type, 2018-2026 (USD Million)
1.2.3.	Influenza Diagnostics Market, by End user, 2018-2026 (USD Million)
1.3.	Key Trends 
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Influenza Diagnostics Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Influenza Diagnostics Market Dynamics	
3.1.	Influenza Diagnostics Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Influenza Diagnostics Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Influenza Diagnostics Market, by Test type 
5.1.	Market Snapshot 
5.2.	Global Influenza Diagnostics Market by Test type, Performance - Potential Analysis
5.3.	Global Influenza Diagnostics Market Estimates & Forecasts by Test type 2016-2026 (USD Million)
5.4.	Influenza Diagnostics Market, Sub Segment Analysis
5.4.1.	  Traditional Diagnostic Tests
5.4.2.	 Molecular Diagnostic Tests
Chapter 6.	Global Influenza Diagnostics Market, by End user          
6.1.	Market Snapshot 
6.2.	Global Influenza Diagnostics Market by End user, Performance - Potential Analysis
6.3.	Global Influenza Diagnostics Market Estimates & Forecasts by End user 2016-2026 (USD Million)
6.4.	Influenza Diagnostics Market, Sub Segment Analysis
6.4.1.	  Hospitals
6.4.2.	Clinical Laboratories
6.4.3.	Other End-User 
Chapter 7.	Global Influenza Diagnostics Market, Regional Analysis
7.1.	Influenza Diagnostics Market, Regional Market Snapshot 
7.2.	North America Influenza Diagnostics Market 
7.2.1.	U.S. Influenza Diagnostics Market
7.2.1.1.	 Test type breakdown estimates & forecasts, 2016-2026 
7.2.1.2.	 End user breakdown estimates & forecasts, 2016-2026 
7.2.2.	Canada Influenza Diagnostics Market
7.3.	Europe Influenza Diagnostics Market Snapshot
7.3.1.	U.K. Influenza Diagnostics Market 
7.3.2.	Germany Influenza Diagnostics Market
7.3.3.	Rest of Europe Influenza Diagnostics Market
7.4.	Asia-Pacific Influenza Diagnostics Market Snapshot
7.4.1.	China Influenza Diagnostics Market 
7.4.2.	India Influenza Diagnostics Market 
7.4.3.	Japan Influenza Diagnostics Market
7.4.4.	Rest of Asia Pacific Influenza Diagnostics Market
7.5.	Latin America Influenza Diagnostics Market Snapshot
7.5.1.	Brazil Influenza Diagnostics Market
7.5.2.	Mexico Influenza Diagnostics Market
7.6.	Rest of The World Influenza Diagnostics Market  

Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	      F. Hoffmann-La Roche AG 
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	Quidel Corporation 
8.2.3.	Thermo Fisher Scientific 
8.2.4.	Abbott Laboratories 
8.2.5.	 Hologic Inc.
8.2.6.	Becton, Dickinson, and Company 
8.2.7.	DiaSorin S.p.A 
8.2.8.	Luminex Corporation 
8.2.9.	Meridian Bioscience Inc.  
8.2.10.	GenMark Diagnostics 
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Influenza Diagnostics Market is valued approximately at USD 646.5 million in 2019 and is anticipated to grow with a growth rate of more than 7.8% over the forecast period 2020-2026. Influenza is an infectious respiratory infection caused via flu viruses. Each year seasonal influenza affects millions of people leading thousands of hospitalizations and flu-related deaths. As per the World Health Organization report 2019, every year there are an estimated 1 billion cases Influenza, about 3-5 million severe cases of influenza, and 290 000-650 000 influenza-associated respiratory deaths worldwide. Influenza outbreaks have encouraged healthcare authorities across the world to upsurge the capacity of influenza diagnosis, which is further contributing towards the adoption of influenza diagnostics. Global influenza diagnostic market growth is mainly driven by aspects such as the growing incidence of influenza, growing in research funding for influenza diagnostics, and the growing demand for faster diagnosis. Furthermore, the increasing approvals of influenza diagnostic products by governing authorities is expected to create significant growth opportunity for the market over the forecast period. For instance, Abbott Laboratories received FDA clearance for ID NOW Influenza A & B 2 Assay product in 2018. Similarly, Quidel Corporation received FDA clearance for QuickVue Influenza A+B Test product. However, complex regulatory framework for the approval of new diagnostic tests impedes the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Influenza Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing prevalence of influenza and advanced healthcare facilities in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as developing healthcare infrastructure, increasing prevalence of diseases would create lucrative growth prospects for the Influenza Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test type:
Traditional Diagnostic Tests
Molecular Diagnostic Tests
By End user:
Hospitals
Clinical Laboratories
Other End-User

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Influenza Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…